1-anilino-8-naphthalenesulfonate has been researched along with Obesity, Morbid in 18 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "05) with serum levels of alanine aminotransferase (ALT), asparate aminotransferase (AST), glucose, fibrinogen, and insulin-dependent diabetes mellitus, homeostasis model assessment-insulin resistance, and presence of NASH." | 3.79 | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. ( Charlton, MR; Gawrieh, S; Guichelaar, MM; Krishnan, A; Malinchoc, M; Olivier, M; Sanderson, S; Sarr, M; Swain, JM; Viker, K; Watt, KD, 2013) |
| "Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and comprises a liver disease spectrum ranging from steatosis to nonalcoholic steatohepatitis (NASH) with risk of progression to liver cirrhosis and hepatocellular carcinoma (HCC)." | 2.52 | Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. ( Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Munda, P; Rechling, C; Trauner, M; Traussnigg, S, 2015) |
| " A multifaceted approach to the obese patient should include identifying potential causes for weight gain, outlining medical conditions that would benefit by weight loss, and tailoring a weight loss program that is safe and effective for the individual." | 2.40 | Safe and effective management of the obese patient. ( Collazo-Clavell, ML, 1999) |
| "Acute pancreatitis is uncommon in children and adolescents, and when it does occur, it is rarely fatal." | 1.56 | Fatal Acute Pancreatitis in an Adolescent: A Case Report. ( Hade, AL; Zumwalt, RE, 2020) |
| "Obesity is the major trigger of nonalcoholic fatty liver disease (NAFLD)." | 1.43 | PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery. ( Alustiza, JM; Banales, JM; Bujanda, L; Emparanza, JI; Jiménez-Agüero, R; Krawczyk, M; Lammert, F; Perugorria, MJ, 2016) |
| "Severe obesity is associated with reduced muscle oxidative capacity and occurs concomitantly with elevated IMTG, ceramide and insulin resistance." | 1.39 | Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity. ( Coen, PM; DeLany, JP; Dubé, JJ; Goodpaster, BH; Hames, KC; Leachman, EM; Menshikova, EV; Ritov, VB; Stefanovic-Racic, M; Toledo, FG, 2013) |
| "We developed a novel NAFLD Liver Inflammation Score, including serum Il-1RA concentration, which performed better to diagnose NASH than did previously published scores." | 1.38 | Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. ( Grönlund, S; Gylling, H; Kainulainen, S; Käkelä, P; Kaminska, D; Kärjä, V; Kuulasmaa, T; Kuusisto, J; Laakso, M; Pääkkönen, M; Pihlajamäki, J; Punnonen, K; Simonen, M, 2012) |
| "In 26 patients with morbid obesity who underwent bariatric surgery, we analyzed different kinds of lipids and hepatic lipase (HL) from both plasma and liver biopsies performed 12-18 months after surgery." | 1.35 | Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content. ( Allende, H; Baena-Fustegueras, JA; Catalán, R; Fort, JM; Galard, R; Lecube, A; Pardina, E; Peinado-Onsurbe, J; Vargas, V, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Hade, AL | 1 |
| Zumwalt, RE | 1 |
| Song, R | 1 |
| Cao, S | 1 |
| Guichelaar, MM | 1 |
| Gawrieh, S | 1 |
| Olivier, M | 1 |
| Viker, K | 1 |
| Krishnan, A | 1 |
| Sanderson, S | 1 |
| Malinchoc, M | 1 |
| Watt, KD | 1 |
| Swain, JM | 1 |
| Sarr, M | 1 |
| Charlton, MR | 1 |
| Coen, PM | 1 |
| Hames, KC | 1 |
| Leachman, EM | 1 |
| DeLany, JP | 1 |
| Ritov, VB | 1 |
| Menshikova, EV | 1 |
| Dubé, JJ | 1 |
| Stefanovic-Racic, M | 1 |
| Toledo, FG | 1 |
| Goodpaster, BH | 1 |
| Ferrer, R | 1 |
| Pardina, E | 2 |
| Rossell, J | 1 |
| Baena-Fustegueras, JA | 2 |
| Lecube, A | 2 |
| Balibrea, JM | 1 |
| Caubet, E | 1 |
| González, O | 1 |
| Vilallonga, R | 1 |
| Fort, JM | 2 |
| Peinado-Onsurbe, J | 2 |
| León-Mimila, P | 1 |
| Vega-Badillo, J | 1 |
| Gutiérrez-Vidal, R | 1 |
| Villamil-Ramírez, H | 1 |
| Villareal-Molina, T | 1 |
| Larrieta-Carrasco, E | 1 |
| López-Contreras, BE | 1 |
| Kauffer, LR | 1 |
| Maldonado-Pintado, DG | 1 |
| Méndez-Sánchez, N | 1 |
| Tovar, AR | 1 |
| Hernández-Pando, R | 1 |
| Velázquez-Cruz, R | 1 |
| Campos-Pérez, F | 1 |
| Aguilar-Salinas, CA | 1 |
| Canizales-Quinteros, S | 1 |
| Traussnigg, S | 1 |
| Kienbacher, C | 1 |
| Halilbasic, E | 1 |
| Rechling, C | 1 |
| Kazemi-Shirazi, L | 1 |
| Hofer, H | 1 |
| Munda, P | 1 |
| Trauner, M | 1 |
| Tai, CM | 1 |
| Huang, CK | 1 |
| Tu, HP | 1 |
| Hwang, JC | 1 |
| Yeh, ML | 1 |
| Huang, CF | 1 |
| Huang, JF | 1 |
| Dai, CY | 1 |
| Chuang, WL | 1 |
| Yu, ML | 1 |
| Aragonès, G | 1 |
| Auguet, T | 1 |
| Armengol, S | 1 |
| Berlanga, A | 1 |
| Guiu-Jurado, E | 1 |
| Aguilar, C | 1 |
| Martínez, S | 1 |
| Sabench, F | 1 |
| Porras, JA | 1 |
| Ruiz, MD | 1 |
| Hernández, M | 1 |
| Sirvent, JJ | 1 |
| Del Castillo, D | 1 |
| Richart, C | 1 |
| Krawczyk, M | 1 |
| Jiménez-Agüero, R | 1 |
| Alustiza, JM | 1 |
| Emparanza, JI | 1 |
| Perugorria, MJ | 1 |
| Bujanda, L | 1 |
| Lammert, F | 1 |
| Banales, JM | 1 |
| Fain, JN | 1 |
| Cheema, P | 1 |
| Tichansky, DS | 1 |
| Madan, AK | 1 |
| Catalán, R | 1 |
| Galard, R | 1 |
| Allende, H | 1 |
| Vargas, V | 1 |
| Romeo, S | 1 |
| Sentinelli, F | 1 |
| Dash, S | 1 |
| Yeo, GS | 1 |
| Savage, DB | 1 |
| Leonetti, F | 1 |
| Capoccia, D | 1 |
| Incani, M | 1 |
| Maglio, C | 1 |
| Iacovino, M | 1 |
| O'Rahilly, S | 1 |
| Baroni, MG | 1 |
| Pihlajamäki, J | 1 |
| Kuulasmaa, T | 1 |
| Kaminska, D | 1 |
| Simonen, M | 1 |
| Kärjä, V | 1 |
| Grönlund, S | 1 |
| Käkelä, P | 1 |
| Pääkkönen, M | 1 |
| Kainulainen, S | 1 |
| Punnonen, K | 1 |
| Kuusisto, J | 1 |
| Gylling, H | 1 |
| Laakso, M | 1 |
| De Naeyer, H | 1 |
| Ouwens, DM | 1 |
| Van Nieuwenhove, Y | 1 |
| Pattyn, P | 1 |
| 't Hart, LM | 1 |
| Kaufman, JM | 1 |
| Sell, H | 1 |
| Eckel, J | 1 |
| Cuvelier, C | 1 |
| Taes, YE | 1 |
| Ruige, JB | 1 |
| Talmud, PJ | 1 |
| Palmen, J | 1 |
| Wolf, AM | 1 |
| Beisiegel, U | 1 |
| Collazo-Clavell, ML | 1 |
| Hauptman, J | 1 |
| Lucas, C | 1 |
| Boldrin, MN | 1 |
| Collins, H | 1 |
| Segal, KR | 1 |
2 reviews available for 1-anilino-8-naphthalenesulfonate and Obesity, Morbid
| Article | Year |
|---|---|
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Topics: Anticholesteremic Agents; Antioxidants; Bariatric Surgery; Carcinoma, Hepatocellular; Disease Progre | 2015 |
Safe and effective management of the obese patient.
Topics: Anti-Obesity Agents; Appetite Depressants; Cognitive Behavioral Therapy; Cyclobutanes; Exercise; Gas | 1999 |
2 trials available for 1-anilino-8-naphthalenesulfonate and Obesity, Morbid
| Article | Year |
|---|---|
Decreased lipases and fatty acid and glycerol transporter could explain reduced fat in diabetic morbidly obese.
Topics: Adiposity; Adult; Aquaporins; Biological Transport; CD36 Antigens; Diabetes Mellitus, Type 2; Down-R | 2014 |
Orlistat in the long-term treatment of obesity in primary care settings.
Topics: Adult; Anti-Obesity Agents; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Double-Blind Met | 2000 |
14 other studies available for 1-anilino-8-naphthalenesulfonate and Obesity, Morbid
| Article | Year |
|---|---|
Fatal Acute Pancreatitis in an Adolescent: A Case Report.
Topics: Acid-Base Imbalance; Adolescent; Blood Glucose; Calcium; Fatal Outcome; Female; Humans; Lipase; Necr | 2020 |
Post-bariatric surgery starvation ketoacidosis and lipase elevation in the absence of DKA or pancreatitis.
Topics: Adult; Diabetic Ketoacidosis; Diagnostic Errors; Female; Gastroplasty; Humans; Ketosis; Lipase; Obes | 2018 |
Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
Topics: Adult; Alleles; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 1; Fatty Liver; Female; F | 2013 |
Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity.
Topics: Adult; Body Composition; Case-Control Studies; Ceramides; Diacylglycerol O-Acyltransferase; Diglycer | 2013 |
A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity.
Topics: Adaptor Proteins, Signal Transducing; Adult; Cholesterol; Chondroitin Sulfate Proteoglycans; Female; | 2015 |
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Topics: Adaptor Proteins, Signal Transducing; Adult; Alleles; Bariatric Surgery; Biopsy; Female; Genetic Pre | 2016 |
PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Topics: Alleles; Cohort Studies; Female; Genotype; Humans; Lipase; Lipid Metabolism; Liver; Liver X Receptor | 2016 |
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
Topics: Adipose Tissue; Adult; Analysis of Variance; Bariatric Surgery; Female; Humans; Lipase; Lipid Metabo | 2016 |
Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone.
Topics: Carrier Proteins; Dexamethasone; Female; Glucocorticoids; Human Growth Hormone; Humans; Interferon-b | 2008 |
Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content.
Topics: Adrenocorticotropic Hormone; Biomarkers; Fatty Liver; Female; Gastric Bypass; Humans; Lipase; Male; | 2009 |
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Body Mass Index; Fatty Liver; | 2010 |
Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans.
Topics: Adult; Aged; Alanine Transaminase; Biomarkers; Biopsy; Fatty Liver; Female; Genotype; Humans; Insuli | 2012 |
Combined gene and protein expression of hormone-sensitive lipase and adipose triglyceride lipase, mitochondrial content, and adipocyte size in subcutaneous and visceral adipose tissue of morbidly obese men.
Topics: Adipocytes; Adult; Aged; C-Reactive Protein; Case-Control Studies; DNA, Mitochondrial; Gene Expressi | 2011 |
Investigation into the role of the hormone sensitive lipase -60C>G promoter variant in morbid obesity.
Topics: Adult; Blood Glucose; Cohort Studies; Female; Gene Frequency; Genetic Variation; Humans; Insulin; Le | 2005 |